Tag Archives: rituximab

New rituximab trial results from Norway

Research abstract: Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is a disease of unknown etiology. We have previously suggested clinical benefit from B-cell depletion using the monoclonal anti-CD20 antibody rituximab in a randomized and placebo-controlled study. Prolonged responses were then demonstrated in … Continue reading

Posted in News | Tagged , , , , , | Comments Off on New rituximab trial results from Norway

Unexpected findings & promoting monocausal claims, a cautionary tale

Article abstract: Stories of serendipitous discoveries in medicine incorrectly imply that the path from an unexpected observation to major discovery is straightforward or guaranteed. In this paper, I examine a case from the field of research about chronic fatigue syndrome (CFS). In Norway, … Continue reading

Posted in News | Tagged , , , , | Comments Off on Unexpected findings & promoting monocausal claims, a cautionary tale

IIMEC 2016 conference report by Dr R Vallings

IIME 11 conference report by Dr Rosamund Vallings MB BS On 3rd June, 2016, I was privileged to attend the 11th Invest in ME – Research International conference in London – the theme being “A New Decade of Invest in ME … Continue reading

Posted in News | Tagged , , , , , , , , , , | Comments Off on IIMEC 2016 conference report by Dr R Vallings

People with ME/CFS have long been told it’s all in their head – these scientists disagree

The Canary blog, 8 June 2016, by Conrad Bower: CFS have long been told it’s all in their head – these scientists disagree A conference bringing together the brightest minds in Myalgic Encephalomyelitis a.k.a Chronic Fatigue Syndrome (ME/CFS) research, presented … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on People with ME/CFS have long been told it’s all in their head – these scientists disagree

ME and rituximab in Notodden Norway

ME-foreldrene blog: Lecture by Hanne Thürmer, Notodden. RituxME and current development, 13 April 2016 Lecture by dr Hanne Thürmer, Notodden Hospital Original in Norwegian/Norsk original From a lecture given at the local department of the Norwegian ME-association in Notodden, avd … Continue reading

Posted in News | Tagged , , , | Comments Off on ME and rituximab in Notodden Norway

Video interview with parent Mary Dimmock about her son and rituximab

Episode 78 of Llewellyn King’s ME/CFS Alert videos interviews Mary Dimmock, whose son has ME and who is receiving RITUXAN (rituximab) treatment privately. (24 mins)    

Posted in News | Tagged , , , , , | Comments Off on Video interview with parent Mary Dimmock about her son and rituximab

CFS & Rituximab revisited

Science based medicine article: Chronic Fatigue Syndrome: Rituximab Revisited by Harriet Hall (the SkepDoc), January 19, 2016 Three years ago I wrote about an experimental treatment for chronic fatigue syndrome (CFS): rituximab (brand name Rituxan). I was concerned that doctors who … Continue reading

Posted in News | Tagged , , , , , , | 1 Comment

IiME rituximab research update

Invest in ME press release: Invest in ME (Research) has created a separate strand to our Biomedical Research Fund which will be explicitly used for this UK rituximab trial. A specific fund-raising thermometer was created just for this project – see  … Continue reading

Posted in News | Tagged , | Comments Off on IiME rituximab research update

B-cell function in patients with ME/CFS

Research summary: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a  heterogeneous condition of unknown etiology characterized by multiple symptoms including fatigue, post-exertional malaise and cognitive impairment, lasting for at least 6 months. Recently, two clinical trials of B-cell depletion therapy with rituximab (anti-CD20) reported convincing … Continue reading

Posted in News | Tagged , , | Comments Off on B-cell function in patients with ME/CFS

To future GPs – psychosomatic should not be the default suspicion re ME/CFS

Time to swot up on chronic fatigue – Future general practitioners need to be made aware that “psychosomatic” should not be the default suspicion, by Michael Brooks in the New Statesman, Nov 12 2015 Around 250,000 people in the UK suffer from … Continue reading

Posted in News | Tagged , , , , , , , , , , | Comments Off on To future GPs – psychosomatic should not be the default suspicion re ME/CFS